Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported Operating Income Loss of -$6.92 million for the year ending 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +10.5% in Operating Income Loss from 2024 to 2025.
- This data is from Harvard Apparatus Regenerative Technology, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: -$1.26 million | Q2 2012: -$1.76 million | Q3 2012: -$1.73 million | Q4 2012: -$1.97 million | Q1 2013: -$2.02 million | Q2 2013: -$2.09 million | Q3 2013: -$2.06 million | Q4 2013: -$2.65 million | Q1 2014: -$3.01 million | Q2 2014: -$2.53 million | Q3 2014: -$2.68 million | Q4 2014: -$2.84 million | Q1 2015: -$2.62 million | Q2 2015: -$4.50 million | Q3 2015: -$2.29 million | Q4 2015: -$2.29 million | Q1 2016: -$2.47 million | Q2 2016: -$2.92 million | Q3 2016: -$3.15 million | Q4 2016: -$3.58 million | Q1 2017: -$3.05 million | Q2 2017: -$3.73 million | Q3 2017: -$3.25 million | Q1 2018: -$1.48 million | Q2 2018: -$2.03 million | Q3 2018: -$2.23 million | Q1 2019: -$2.03 million | Q2 2019: -$2.67 million | Q3 2019: -$2.50 million | Q1 2020: -$1.90 million | Q2 2020: -$1.26 million | Q3 2020: -$1.06 million | Q1 2021: -$995.0 thousand | Q2 2021: -$918.0 thousand | Q3 2021: -$822.0 thousand | Q1 2022: -$2.21 million | Q2 2022: -$1.38 million | Q3 2022: -$1.08 million | Q1 2023: -$2.89 million | Q2 2023: -$2.65 million | Q3 2023: -$1.62 million | Q1 2024: -$2.02 million | Q2 2024: -$2.48 million | Q3 2024: -$1.86 million | Q1 2025: -$1.67 million | Q2 2025: -$1.83 million | Q3 2025: -$1.71 million.
- Over the full 14 years of available data (2012 to 2025), Harvard Apparatus Regenerative Technology, Inc.'s Operating Income Loss has declined by 3.0%.
- Historical annual values: Fiscal year 2025: -$6.92 million | Fiscal year 2024: -$7.73 million | Fiscal year 2023: -$8.99 million | Fiscal year 2022: -$6.15 million | Fiscal year 2021: -$8.64 million | Fiscal year 2020: -$5.33 million | Fiscal year 2019: -$8.87 million | Fiscal year 2018: -$7.84 million | Fiscal year 2017: -$11.47 million | Fiscal year 2016: -$12.13 million | Fiscal year 2015: -$11.70 million | Fiscal year 2014: -$11.06 million | Fiscal year 2013: -$8.82 million | Fiscal year 2012: -$6.71 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: